BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Elorac, Inc. 

1126 Crenshaw Boulevard

Torrance  California  90501  U.S.A.
Phone: 310-533-1644 Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Scott Phillips, M.D. Joins Elorac, Inc. As Senior Vice President, Scientific Affairs 3/25/2014 7:44:42 AM    More...
Elorac, Inc. To Present At RBC Capital Markets 2014 Healthcare Conference 2/7/2014 6:42:57 AM    More...
U.S. Patent & Trademark Office (USPTO) Issues Patent To Elorac, Inc. For Novel Acne Therapy 2/5/2014 11:17:09 AM    More...
Elorac, Inc. Receives Notice of Allowance From U.S. Patent Office for Novel Acne Therapy 9/26/2013 10:36:03 AM    More...
Elorac, Inc. Announces FDA Fast Track Designation for Novel Topical Treatment for Pruritus in Cutaneous T-cell Lymphoma (CTCL) 4/12/2013 9:28:02 AM    More...
Elorac, Inc. Announces Orphan Designation in Europe for Novel Topical Treatment for Cutaneous T-Cell Lymphoma (CTCL) 11/16/2012 9:02:20 AM    More...
Elorac, Inc. Gives Back to Young Campers with Chronic Skin Conditions Through a Generous Donation to Camp Discovery 12/20/2011 8:59:50 AM    More...
Elorac, Inc. Promotes Christopher Gabanski as Chief Commercial Officer 7/22/2011 6:25:01 AM    More...
Elorac, Inc. Announces Orphan Drug Designation for Novel Topical Treatment for Pruritus in Cutaneous T-cell Lymphoma (CTCL) 11/30/2010 9:11:54 AM    More...
Elorac, Inc. Announces Clinical Results of Carbamide Peroxide Studies for the Treatment of Acne 11/19/2010 10:41:53 AM    More...
12